“Two fifths of men in developing countries still smoke or use tobacco, and women are increasingly starting to smoke at younger ages, according to a large international study which found ‘alarming patterns’ of tobacco use,” Reuters reports (Kelland, 8/17). The study, published Friday in the Lancet, “covered enough representative samples to estimate tobacco use among three billion people” and “‘demonstrates an urgent need for policy change in low- and middle-income countries,’ said lead researcher Gary Giovino,” according to CNN (Levs, 8/17). “‘Although 1.1 billion people have been covered by the adoption of the most effective tobacco control policies since 2008, 83 percent of the world’s population are not covered by two or more of these policies,’ said [Giovino],” Reuters adds (8/17).
Non Communicable Disease/Chronic Disease
“Australia’s highest court Wednesday rejected a challenge from big tobacco companies to tough new plain-packaging laws due to come into effect later this year, in a legal battle closely watched around the world,” the Wall Street Journal reports, adding, “The ruling is a major blow for global tobacco giants that had been seeking to stop Australia implementing the new laws, fearing the move would set a precedent for other countries to follow” (Curran, 8/14). “Tobacco companies British American Tobacco, Britain’s Imperial Tobacco, Philip Morris and Japan Tobacco challenged the laws in Australia’s high court, claiming the rules were unconstitutional because they effectively extinguished the companies’ intellectual property rights,” according to the Guardian (8/15). “The law, approved by Parliament last year, requires cigarettes to be sold in drab dark packaging starting in December, without logos but featuring graphic images of smoking-related diseases,” the Washington Post writes, adding, “Brand names can still be used, but only in a standard font, size and position” (Hume, 8/15).
One Blog Examines GAVI Alliance's Efforts To Accelerate Introduction Of Hepatitis B Vaccines In Developing Countries
“I am looking forward to participating in the 2012 World Cancer Leaders’ Summit, to be held in Montreal, Canada on August 27,” GAVI Alliance Deputy CEO Helen Evans writes in this post in the One Blog. “This will be an opportunity to take stock of where the world is with regards to cancer prevention and treatment and to learn more about action to address the existing challenges to eliminating cancer as a life-threatening disease for future generations,” she writes, and discusses GAVI’s efforts to “accelerat[e] the introduction of hepatitis B vaccines in developing countries since 2000,” noting “GAVI has helped prevent an estimated 3.7 million deaths from liver cancer (caused by hepatitis B)” (8/21).
The Associated Press/Seattle Times reports on a “mysterious epidemic [that] is devastating the Pacific Coast of Central America, killing more than 24,000 people in El Salvador and Nicaragua since 2000 and striking thousands of others with chronic kidney disease at rates unseen virtually anywhere else.” The news service provides statistics regarding kidney disease in various Central American countries, quotes a number of experts regarding potential causes of the disease and notes, “While some of the rising numbers may be from better record-keeping, scientists believe they are facing something deadly and previously unknown to medicine.”
New York Mayor Michael Bloomberg on Thursday announced his charitable foundation will “spend $220 million over the next four years to discourage tobacco use in developing countries, as he seeks to promote strategies around the world that curbed smoking in his city,” the Wall Street Journal reports (McKay, 3/21). Bloomberg announced “the new funding for Bloomberg Philanthropies on Thursday at the 15th World Conference on Tobacco or Health in Singapore,” Reuters writes, noting “[t]he commitment takes the foundation’s total pledge to the cause to almost $600 million” (Begley et al., 3/22).
IPS Reports On Research Study Examining Knowledge, Beliefs Of Cervical Cancer Among Argentinian Women
Inter Press Service reports on a research study conducted in Argentina that “explored women’s knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies.” The news service writes, “Although there are now effective tools to prevent cervical cancer, and vaccination against human papillomavirus (HPV) is free and mandatory for 11-year-old girls, the death rate from cervical cancer is not declining in Argentina, and the geographical distribution of the burden is extremely unequal.”
The “improvement and extension of health care in Africa is … being constrained by gaps in financing,” according to a new report (.pdf) by the Economist Intelligence Unit (EIU) based on research commissioned by Janssen Pharmaceutica, a Belgian subsidiary of Johnson & Johnson, the Financial Times’ “beyondbrics” blog reports (Wheatley, 3/1). The report, titled “The Future of Healthcare in Africa,” “discusses the continent’s traditional health care issues, such as communicable diseases or financing health care in economically difficult circumstances” and “also addresses less well-known topics, such as the threat of obesity and heart disease, the use of mobile technology, development of more preventive care, and more,” according to the Janssen website (3/1). The report “identif[ies] the key trends shaping African health care systems” and uses them “to develop [five] scenarios that depict the possible health landscape on the continent in 2022,” a Janssen press release (.pdf) states (3/1).
The March issue of the WHO Bulletin features an editorial on global shortages of medicines; a public health round-up; an article on breast cancer awareness; a research paper on interventions for the prevention of mother-to-child HIV transmission in Kwa-Zulu Natal, South Africa; and a paper on the global burden of cholera (March 2012).
This week the WHO brought together lawmakers from across Southeast Asia in Bangkok “to discuss how to bolster their health systems back home,” IRIN reports. Meeting participants were “called on to advocate the boosting of health spending, workforces and access to health care in their home countries in addition to drafting ‘healthy public policies,’ such as conducting health assessments before large infrastructural projects are undertaken,” the news service writes.
Guardian health editor Sarah Boseley examines why children have been excluded from WHO targets on non-communicable diseases (NCDs) in this post in her “Global Health Blog,” writing, “Children die from cancer, heart disease and other [NCDs] but they are in danger of being forgotten as global targets for action are drawn up, say health groups.” Boseley discusses an analysis by advocate Kate Armstrong, which suggests “the targets now being considered by the [WHO] and others to reduce the impact of heart disease, cancer and other [NCDs] are in danger of being focused solely on adults,” as “the targets under consideration aim to bring down the deaths of adults over the age of 30.”